Search
DBS Restores Function for Parkinson’s Patient Through New “Sensing” Pacemaker: A UCSF Case Study
This study allows researchers to continuously record brain physiology from the DBS electrode and automatically adjust the stimulation intensity based on these signals.Strategies for Reducing Length of Hospital Stay for Patients With Acute Severe Ulcerative Colitis
In a first-of-its-kind study, UCSF researchers assessed factors prolonging length of stay (LOS) for a diverse population of hospitalized patients with acute severe ulcerative colitis (ASUC) and identified interventions to reduce LOS for these patients.Abortion Ban May Increase Risk of Death for Pregnant Women with Cancer
The repercussions of overturning Roe v. Wade – and the failure of the Supreme Court to provide any guidance on exceptions related to the life and health of the mother – are potentially catastrophic for a subset of women who face a life-threating diagnosis of pregnancy associated cancers (PAC).Research Leads to New Myocarditis Diagnostic and Treatment Strategies
Research conducted by Javid Moslehi, MD, chief of the UCSF Cardio-Oncology and Immunology Program, has led to the discovery of a new form of myocarditis caused by immune checkpoint inhibitors (ICI).New Guidance for Ethical Urinary Incontinence Care for Older Adults
An International Continence Society working group led by UCSF urologist Anne M. Suskind, MD, MS, FACS, FPM-RS, recently published a white paper that provides an ethical framework for caring for older adults with urinary incontinence.Brachytherapy Improves Outcomes for Cervical Cancer Patients
Patients with locally advanced cervical cancer who receive chemoradiation therapy and brachytherapy and complete treatment within eight weeks have a superior overall survival rate compared to those who don’t receive this treatment, according to a UCSF study.New Research Linking Type 1 Diabetes to Genetic Mutations May Lead to Precision Medicine
UCSF researchers have discovered specific genetic mutations that can cause type 1 diabetes. This groundbreaking work could result in effective precision treatments for patients.Artificial Intelligence and Wearable Sensors Put the Gait Lab in the Patient’s Pocket
UCSF orthopaedic surgeon Stefano Bini, MD, in collaboration with Google’s Advanced Technologies and Products (ATAP) division, is developing technology that will revolutionize how providers measure joint function and quantify joint disease. This groundbreaking approach uses cutting-edge machine-learning algorithms and data collected from inexpensive, wearable inertial sensors to accurately replicate gait lab outputs for a fraction of the cost of traditional methods, and in any context.Renal Cell Carcinoma Research Sheds New Light on Advanced Disease
In a recent study, UCSF researchers found that renal cell carcinoma (RCC)with venous tumor thrombus(VTT) does not always signify metastatic disease with poor prognosis. These findings provide insight into the development of advanced RCC and may help to better inform surveillance regimens and treatment decisions and, ultimately, improve clinical outcomes.Electrophysiology and Arrhythmia Program
The UCSF Cardiac Electrophysiology and Arrhythmia Service is known worldwide for expert evaluation and treatment of patients with a variety of heart rhythm disorders.Renowned Pulmonary Disease Specialist to Lead UCSF Pulmonology Program
Prescott Woodruff, MD, MPH, a renowned leader in the pathogenesis and treatment of airway disease, has been appointed chief of UC San Francisco’s Division of Pulmonary, Critical Care, Allergy and Sleep Medicine. Prescott will assume the role of chief on July 1.Novel Hyperglycemia Management Protocol for Patients Undergoing Cancer Treatment
An innovative hyperglycemia management protocol for patients receiving cancer therapy is provided through an urgent-care site within the UCSF Infusion Center, and can be replicated at other centers. The protocol ensures that patients promptly get the necessary treatment for acute hyperglycemia that can occur during cancer therapy.Seizures Stopped, Speech Preserved After Rare Auditory Cortex Tumor is Removed: A UCSF Case Study
The extraordinary success was made possible through research on the neural mechanisms of speech by Edward Chang, MD, UCSF neurosurgeon and chair of the Department of Neurological Surgery, and an advanced phase 2 surgical evaluation by the UCSF Epilepsy Center team.Renowned Expert to Lead UCSF’s Hematology and Oncology Division
Krishna Komanduri, MD, an international leader in hematology-oncology, transplantation and cellular immunotherapy, is the new chief of UCSF’s Division of Hematology and Oncology.UCSF Prostate Cancer Specialist Inducted into Annual Class of “Giants of Cancer Care”
Eric Small, MD, has been announced as one of the winners of the 10th annual Giants of Cancer Care® awards.New Research on Cell Regeneration Shows Promise for Treating Lung Injury and Fibrosis
In a new study, UCSF researchers showed that they could successfully redirect profibrotic murine lung cells to a nonfibrotic state in which they regenerated alveoli. These findings could lead to novel treatments for lung injury and fibrosis.New Tinnitus Research Focused on Neural Networks Shows Promise for Precision Treatment
Using advanced neuroimaging, UCSF researchers are exploring the root causes of tinnitus and developing novel treatments for this potentially debilitating condition, which affects more than 50 million Americans.Genetic Gut Microbiome Variations Point to Precision Treatments for Metabolic Conditions
In a new study, UCSF researchers found that the gut microbiome of East Asians is distinct from that of White individuals living in the same geographic region. This discovery may lead to personalized treatments for various metabolic conditions, including diabetes and obesity.UCSF Lung Transplant Patient No. 1,000 Looks Ahead to More of the Good Life
Hospital Innovations Boost 3-Year Survival From 50% in 2001 to 90% 20 Years LaterAdvancing Precision Medicine for Neuro-Oncology Patients: Q&A with David Solomon, MD, PhD
UC San Francisco neuropathologist and molecular neuro-oncologist David Solomon, MD, PhD has reached a unique and impressive milestone: the publication of his team's 50th neuro-oncology research study stemming from the UCSF500 Cancer Gene Panel, a molecular diagnostic test that identifies genetic changes in the DNA of a patient's cancer.Best Practices for Implementing Virtual and Hybrid Cardiac Rehabilitation Programs
In a new study, UCSF researchers found that patients participating in either virtual or hybrid cardiac rehabilitation (CR) programs showed similar improvements in functional capacity to those of in-person CR program participants. Hybrid programs combine in-person and virtual delivery.Precision Prostate Cancer Treatment Reduces ADT-Related Dementia Risk
In a new study, UCSF researchers found that cumulative androgen deprivation therapy (ADT) exposure was associated with the onset of dementia in a nationwide longitudinal registry of men with prostate cancer.Virtual Cardiac Rehabilitation Produces Similar Results as In-Person Treatment
UCSF Study Shows Potential Benefit of Expanding Availability for Patients Cardiac rehabilitation (CR) reduces hospitalization and mortality and improves quality of life for patients with cardiovascular disease. Despite its benefits, only 24 percent of eligible patients in the U.S. participate in CR due to financial and logistical barriers.Endoscopic Removal of Benign Complex Colorectal Lesions Improves Patient Outcomes
Endoscopic mucosal resection (EMR) is a safe and effective alternative to surgery for benign complex colorectal lesions, according to research led by UCSF gastroenterologist Tonya Kaltenbach, MD.